Malaria Diagnostics Market Size, Share, Growth Analysis, By Diagnostic Test(Rapid Diagnostic Tests, Molecular Diagnostic Tests and Microscopic Diagnostic Tests.), By End-User(Hospitals, Diagnostics Centers and Clinics), By Region - Industry Forecast 2025-2032


Report ID: SQMIG35B2208 | Region: Global | Published Date: May, 2024
Pages: 219 |Tables: 61 |Figures: 75

Malaria Diagnostics Market Insights

Malaria Diagnostics Market size was valued at USD 844.51 Million in 2023 and is poised to grow from USD 884.46 Million in 2024 to USD 1340.65 Million by 2032, growing at a CAGR of 4.73% during the forecast period (2025-2032).

Malaria is a parasitic disease which is transmitted through the bite of an infected anopheles mosquitoes. These mosquitoes carry the Plasmodium parasite, which is then transmitted to humans during a bite. Upon entering the human body, these parasites initially grow in the liver before entering the bloodstream and infect the red blood cells. Common symptoms of malaria in humans include fever, vomiting, weakness, and headache. Over recent years, there has been a significant expansion in the global market for malaria diagnostics.

In recent years, the global malaria diagnostics market has witnessed notable growth, driven by key trends and innovations in diagnostic technologies. Technological advancements, particularly in molecular diagnostics and RDTs, have changed the malaria diagnosis by offering greater sensitivity, specificity and ease of use. Moreover, the increasing adoption of point-of-care testing solutions has facilitated timely diagnosis, especially in resource-limited settings where access to laboratory facilities is limited. The rising awareness about the importance of early detection of malaria along with the government initiatives and fundings from organizations like the global fund, has pushed the market growth while encouraging the development and deployment of innovative diagnostic tools.

However, the market faces several restraints that could impede its growth trajectory. Limited healthcare infrastructure and access to diagnostic services in remote and underserved regions pose significant challenges for malaria diagnosis. Affordability and accessibility of diagnostic tests remain key concerns, particularly in low-income countries where the burden of malaria is highest. Moreover, accuracy and reliability issues with some diagnostic tests, as well as regulatory hurdles, may hinder market expansion efforts. Addressing these challenges will require collaborative efforts from stakeholders across the public and private sectors to develop cost-effective, reliable, and culturally sensitive diagnostic solutions that can effectively combat malaria on a global scale.

Market snapshot - 2025-2032

Global Market Size

USD 786.51 million

Largest Segment

Rapid Diagnostic Tests

Fastest Growth

Molecular Diagnostic Tests

Growth Rate

4.73% CAGR

Global Malaria Diagnostics Market ($ Bn)
Country Share for Middle East & Africa Region (%)

To get more reports on the above market click here to Buy The Report

Malaria Diagnostics Market Segmental Analysis

The global malaria diagnostics market is by diagnostic tests, end-user and region. Based on diagnostics test, the market is segmented into rapid diagnostic tests, molecular diagnostic tests and microscopic diagnostic tests. Based on end-user, the market is segmented into hospitals, diagnostic centres and clinics. And lastly, based on region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.

Analysis by Diagnostic Tests

Based on diagnostics test, the market is segmented into rapid diagnostic tests, molecular diagnostic tests and microscopic diagnostic tests.

The rapid diagnostic tests are the largest segment in the global malaria diagnostics market. The Rapid Diagnostic Tests (RDTs) segment was accounted for a revenue share of 53.69% in 2022. RDTs have gained importance due to their ease of use, rapid results and suitable for use in limited resource environment where malaria is most prevalent. Unlike microscopy, which requires skilled personnel and laboratory infrastructure, RDTs can be performed by minimally trained personnel, making them accessible even in remote areas. RDTs offer quick results, typically within 15-20 minutes and helps in quick diagnosis and timely treatment initiation, which is crucial for effective management of malaria. This further drives the demand in places where patients are in huge amounts. Hence, the convenience, accessibility, and efficiency of RDTs position them as the largest segment in the malaria diagnostics market.

The fastest-growing segment in the global malaria diagnostics market is Molecular Diagnostic Tests segment. Molecular diagnostic tests, such as polymerase chain reaction (PCR) assays, are gaining momentum due to their high sensitivity and specificity in detecting malaria parasites, even at low levels of infection. These tests offer several advantages over traditional methods like microscopy and RDTs such as their ability to detect different species of malaria parasites and differentiate between active infection and past exposure. Furthermore, new advancements in molecular technologies have led to the development of more portable, affordable, and user-friendly molecular diagnostic platforms, expanding their utility in diverse settings. With increasing emphasis on accurate diagnosis for malaria elimination and eradication efforts, the demand for molecular diagnostic tests is expected to rise steadily, making it the fastest-growing segment in the malaria diagnostics market.

Analysis by End-User

Based on end-user, the market is segmented into hospitals, diagnostics centres and clinics.

The largest segment in the malaria diagnostics market is the hospitals segment. Hospitals serve as the central hub for healthcare delivery, offering a wide range of medical services including diagnosis and treatment of malaria cases. They often have comprehensive laboratory facilities equipped with various diagnostic tools and technologies, allowing for prompt and accurate malaria testing. Hospitals cater to a diverse patient population, including individuals seeking treatment for severe malaria cases, making malaria diagnosis a routine part of their services. Moreover, hospitals typically have access to skilled healthcare professionals, including laboratory technicians and infectious disease specialists, ensuring high-quality malaria diagnosis and management.

The diagnostic centres segments are the fastest-growing segment in the malaria diagnostics market. Diagnostic centres are specialized facilities solely focused on diagnostic procedures which also includes malaria testing. They offer several advantages contributing to their rapid growth. Firstly, diagnostic centres often use advanced technologies and equipment, allowing for highly accurate and efficient malaria diagnosis. Secondly, these centres are increasingly being established in urban and rural areas, improving access to diagnostic services, especially in underserved regions where malaria is endemic. lastly, they also often provide specialized services and expertise, attracting patients seeking precise and timely diagnosis for malaria and other infectious diseases. Furthermore, with the growing emphasis on early detection and management of malaria for effective disease control and eradication, the demand for specialized diagnostic centres offering dedicated malaria testing services is expected to rise, making it the fastest-growing segment in the malaria diagnostics market.

Global Malaria Diagnostics Market By Daignostic Test

To get detailed analysis on other segments, Request For Free Sample Report

Malaria Diagnostics Market Regional Insights

Based on the geography, the global malaria diagnostics market is segmented into North America, Asia Pacific, Europe, Latin America, and Middle East & Africa. Middle East & Africa is considered as the leading region in the global malaria diagnostics market. The African region had the highest revenue share of 88.17% in 2022. P. falciparum is the most prevalent malarial parasite in this region and was accounted for an estimated 99% of all cases in Africa. According to the WHO, an estimated 92.0% of global malaria cases and 93% of global malarial deaths were recorded in this region. These facts are indicative of the rising prevalence of malaria in Africa. This region bears the highest burden of malaria globally, with a substantial portion of malaria cases and deaths occurring here. Factors contributing to the dominance of this segment include the endemic nature of malaria in many countries across Africa, where the disease is a major public health concern. Additionally, limited access to healthcare resources, including diagnostic facilities and trained personnel, often demands for the use of RDTs and other point-of-care diagnostics in resource-constrained settings. Moreover, international organizations, governments and non-profit organizations have been actively involved in scaling up malaria control and elimination efforts in the region, thereby driving the demand for malaria diagnostics.

The fastest-growing region in the global malaria diagnostics market is likely the Asia Pacific. While Africa bears the highest burden of malaria globally, Asia Pacific is experiencing significant strides in malaria control and elimination efforts. In Southeast Asia, the market is estimated to hold the second position with India accounting for the largest share of the regional market. The Southeast Asian region is expected to grow at a CAGR of 5.0%. Countries such as India, Indonesia, and Myanmar, have made considerable progress in reducing malaria transmission through extensive vector control measures, improved access to healthcare services, and effective treatment strategies. As a result, there is a growing emphasis on accurate and timely diagnosis of malaria to support these elimination efforts. With the rising awareness about the disease and increasing funding from the private sector, the need for diagnostic testing and care-based surveillance systems is anticipated to increase. Huge investments in healthcare infrastructures and collaborations between governments, international organizations, and private sectors are driving the expansion of malaria diagnostic services in the Asia Pacific region.

Global Malaria Diagnostics Market By Region
  • Largest
  • Fastest

To know more about the market opportunities by region and country, click here to
Buy The Complete Report

Malaria Diagnostics Market Dynamics

Drivers

Higher Malaria Burden in Endemic Regions

  • Regions with a high burden of malaria, particularly in sub-Saharan Africa and parts of Asia, drive the demand for malaria diagnostics. The need for accurate and timely diagnosis is crucial for effective disease management and control.

Rising Travel and Migration

  • Increasing global travel and migration contribute to the spread of malaria to non-endemic regions. This necessitates the availability of malaria diagnostics in areas where the disease is not traditionally prevalent, driving the global demand for diagnostic tests.

Restraints

Limited Research and Development

  • Insufficient investment in research and development for malaria diagnostics may limit the availability of innovative and improved diagnostic technologies. A lack of funding for research initiatives focused on developing more sensitive, specific, and affordable diagnostic tests hampers progress in the field.

Resistance to Antimalarial Drugs

  • The emergence of drug-resistant malaria strains poses challenges for accurate diagnosis and effective treatment. Resistance to frontline antimalarial drugs complicates case management and may require alternative diagnostic approaches and treatment strategies.

Request Free Customization of this report to help us to meet your business objectives.

Malaria Diagnostics Market Competitive Landscape

The global malaria diagnostics market is moderately competitive and consists of several major players. It is characterised by the presence of established multinational corporations, mid-sized companies, and emerging players. Key players such as Abbott Laboratories, BioMérieux SA, and F. Hoffmann-La Roche Ltd dominate the market with their extensive product portfolios, global presence, and strong distribution networks. These companies invest significantly in R&D activities to innovate and introduce advanced diagnostic technologies for malaria detection. Additionally, strategic collaborations, partnerships, and mergers and acquisitions are common strategies employed by market players to expand their market share and enhance their competitive position. However, the market also witnesses the entry of smaller players and startups focusing on niche segments or innovative diagnostic approaches, contributing to market dynamism and fostering competition. The competitive landscape of the malaria diagnostics market is driven by technological advancements, regulatory approvals, market expansion efforts, and the pursuit of novel diagnostic solutions to address the global burden of malaria effectively.

Top Player’s Company Profiles

  • Abbott Laboratories (United States)
  • Beckman Coulter, Inc. (United States)
  • BioMérieux SA (France)
  • Bio-Rad Laboratories, Inc. (United States)
  • Cepheid Inc. (United States)
  • Danaher Corporation (United States)
  • F. Hoffmann-La Roche Ltd (Switzerland)
  • FujiFilm Corporation (Japan)
  • GenMark Diagnostics, Inc. (United States)
  • Hologic, Inc. (United States)
  • Illumina, Inc. (United States)
  • Meridian Bioscience, Inc. (United States)
  • Qiagen NV (Netherlands)
  • Siemens Healthineers AG (Germany)
  • Sysmex Corporation (Japan)
  • Thermo Fisher Scientific Inc. (United States)
  • Bio-Rad Laboratories (United States)
  • Trinity Biotech plc (Ireland)
  • Siemens Healthineers (Germany)
  • Access Bio, Inc. (South Korea)

Recent Developments

  • In March 2022, Novartis announced the launch of its novel rapid diagnostic test (RDT) for malaria, called "ParaQuick," designed for use in remote and resource-limited settings.
  • In April 2022, Chembio Diagnostics, Inc. introduced its multiplex malaria antigen detection test, "DPP Malaria Assay," offering simultaneous detection of multiple malaria species in a single test.
  • In July 2022, PATH, a global health organization, collaborated with Cepheid Inc. to develop a point-of-care molecular diagnostic test for malaria, aiming to provide accurate and rapid diagnosis in endemic regions.
  • In August 2022, Becton, Dickinson and Company launched its automated malaria detection system, "BD MAX Malaria Assay," designed to streamline the diagnosis of malaria infections with improved accuracy and efficiency.
  • In October 2022: FIND (Foundation for Innovative New Diagnostics) and Alere Inc. (now part of Abbott) announced the expansion of their partnership to accelerate the development and deployment of malaria diagnostic tools in resource-limited settings.

Malaria Diagnostics Key Market Trends

  • Expansion into Emerging Markets: Emerging economies in Asia, Latin America, and Africa presents major growth opportunities for malaria diagnostics due to increasing healthcare expenditure, rising awareness about infectious diseases, and government initiatives to combat malaria. Companies can capitalize on these markets by offering cost-effective and culturally sensitive diagnostic solutions tailored to local needs.
  • Awareness and Education: There is a need for increased awareness and education about the importance of early malaria diagnosis, especially in endemic regions. Investing in educational campaigns targeting healthcare professionals, community health workers, and the public can help promote the uptake of malaria diagnostic tests and improve case detection rates.
  • Surveillance and Monitoring: There is a growing emphasis on strengthening malaria surveillance and monitoring systems to track disease transmission, identify hotspots, and assess the effectiveness of control interventions. Developing integrated surveillance tools and data analytics platforms for real-time monitoring of malaria cases can provide valuable insights for decision-making and resource allocation.

Malaria Diagnostics Market SkyQuest Analysis

SkyQuest’s ABIRAW (Advanced Business Intelligence, Research & Analysis Wing) is our Business Information Services team that Collects, Collates, Co-relates, and Analyses the Data collected by means of Primary Exploratory Research backed by robust Secondary Desk research.

According to our global malaria diagnostics market analysis, the malaria diagnostics market is expected a promising growth potential, driven by advancements in diagnostic technologies, increasing awareness about the importance of early detection, and strategic initiatives from global health organizations. based on diagnostic tests, rapid diagnostic tests are dominating due to their accessibility and ease of use, while molecular diagnostic tests offer enhanced accuracy and sensitivity. And based on end-users, hospitals are considered as the biggest users in the market. Regional insights highlight significant opportunities for market expansion in emerging economies, particularly in Asia Pacific and Africa, where the burden of malaria is high. However, challenges such as limited healthcare infrastructure, affordability issues, and regulatory constraints remain key restraints that need to be addressed. Despite these challenges, concerted efforts from stakeholders across sectors can pave the way for the development of innovative, accessible, and reliable diagnostic solutions, ultimately contributing to the global fight against malaria.

 

Report Metric Details
Market size value in 2023 USD 844.51 Million
Market size value in 2032 USD 1340.65 Million
Growth Rate 4.73%
Base year 2024
Forecast period 2025-2032
Forecast Unit (Value) USD Million
Segments covered
  • Diagnostic Test
    • Rapid Diagnostic Tests, Molecular Diagnostic Tests and Microscopic Diagnostic Tests.
  • End-User
    • Hospitals, Diagnostics Centers and Clinics
Regions covered North America (US, Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe), Asia Pacific (China, India, Japan, Rest of Asia-Pacific), Latin America (Brazil, Rest of Latin America), Middle East & Africa (South Africa, GCC Countries, Rest of MEA)
Companies covered
  • Abbott Laboratories (United States)
  • Beckman Coulter, Inc. (United States)
  • BioMérieux SA (France)
  • Bio-Rad Laboratories, Inc. (United States)
  • Cepheid Inc. (United States)
  • Danaher Corporation (United States)
  • F. Hoffmann-La Roche Ltd (Switzerland)
  • FujiFilm Corporation (Japan)
  • GenMark Diagnostics, Inc. (United States)
  • Hologic, Inc. (United States)
  • Illumina, Inc. (United States)
  • Meridian Bioscience, Inc. (United States)
  • Qiagen NV (Netherlands)
  • Siemens Healthineers AG (Germany)
  • Sysmex Corporation (Japan)
  • Thermo Fisher Scientific Inc. (United States)
  • Bio-Rad Laboratories (United States)
  • Trinity Biotech plc (Ireland)
  • Siemens Healthineers (Germany)
  • Access Bio, Inc. (South Korea)
Customization scope

Free report customization with purchase. Customization includes:-

  • Segments by type, application, etc
  • Company profile
  • Market dynamics & outlook
  • Region

To get a free trial access to our platform which is a one stop solution for all your data requirements for quicker decision making. This platform allows you to compare markets, competitors who are prominent in the market, and mega trends that are influencing the dynamics in the market. Also, get access to detailed SkyQuest exclusive matrix.

Buy The Complete Report to read the analyzed strategies adopted by the top vendors either to retain or gain market share

Table Of Content

Executive Summary

Market overview

  • Exhibit: Executive Summary – Chart on Market Overview
  • Exhibit: Executive Summary – Data Table on Market Overview
  • Exhibit: Executive Summary – Chart on Malaria Diagnostics Market Characteristics
  • Exhibit: Executive Summary – Chart on Market by Geography
  • Exhibit: Executive Summary – Chart on Market Segmentation
  • Exhibit: Executive Summary – Chart on Incremental Growth
  • Exhibit: Executive Summary – Data Table on Incremental Growth
  • Exhibit: Executive Summary – Chart on Vendor Market Positioning

Parent Market Analysis

Market overview

Market size

  • Market Dynamics
    • Exhibit: Impact analysis of DROC, 2021
      • Drivers
      • Opportunities
      • Restraints
      • Challenges
  • SWOT Analysis

KEY MARKET INSIGHTS

  • Technology Analysis
    • (Exhibit: Data Table: Name of technology and details)
  • Pricing Analysis
    • (Exhibit: Data Table: Name of technology and pricing details)
  • Supply Chain Analysis
    • (Exhibit: Detailed Supply Chain Presentation)
  • Value Chain Analysis
    • (Exhibit: Detailed Value Chain Presentation)
  • Ecosystem Of the Market
    • Exhibit: Parent Market Ecosystem Market Analysis
    • Exhibit: Market Characteristics of Parent Market
  • IP Analysis
    • (Exhibit: Data Table: Name of product/technology, patents filed, inventor/company name, acquiring firm)
  • Trade Analysis
    • (Exhibit: Data Table: Import and Export data details)
  • Startup Analysis
    • (Exhibit: Data Table: Emerging startups details)
  • Raw Material Analysis
    • (Exhibit: Data Table: Mapping of key raw materials)
  • Innovation Matrix
    • (Exhibit: Positioning Matrix: Mapping of new and existing technologies)
  • Pipeline product Analysis
    • (Exhibit: Data Table: Name of companies and pipeline products, regional mapping)
  • Macroeconomic Indicators

COVID IMPACT

  • Introduction
  • Impact On Economy—scenario Assessment
    • Exhibit: Data on GDP - Year-over-year growth 2016-2022 (%)
  • Revised Market Size
    • Exhibit: Data Table on Malaria Diagnostics Market size and forecast 2021-2027 ($ million)
  • Impact Of COVID On Key Segments
    • Exhibit: Data Table on Segment Market size and forecast 2021-2027 ($ million)
  • COVID Strategies By Company
    • Exhibit: Analysis on key strategies adopted by companies

MARKET DYNAMICS & OUTLOOK

  • Market Dynamics
    • Exhibit: Impact analysis of DROC, 2021
      • Drivers
      • Opportunities
      • Restraints
      • Challenges
  • Regulatory Landscape
    • Exhibit: Data Table on regulation from different region
  • SWOT Analysis
  • Porters Analysis
    • Competitive rivalry
      • Exhibit: Competitive rivalry Impact of key factors, 2021
    • Threat of substitute products
      • Exhibit: Threat of Substitute Products Impact of key factors, 2021
    • Bargaining power of buyers
      • Exhibit: buyers bargaining power Impact of key factors, 2021
    • Threat of new entrants
      • Exhibit: Threat of new entrants Impact of key factors, 2021
    • Bargaining power of suppliers
      • Exhibit: Threat of suppliers bargaining power Impact of key factors, 2021
  • Skyquest special insights on future disruptions
    • Political Impact
    • Economic impact
    • Social Impact
    • Technical Impact
    • Environmental Impact
    • Legal Impact

Market Size by Region

  • Chart on Market share by geography 2021-2027 (%)
  • Data Table on Market share by geography 2021-2027(%)
  • North America
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • USA
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Canada
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Europe
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • Germany
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Spain
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • France
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • UK
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of Europe
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Asia Pacific
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • China
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • India
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Japan
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • South Korea
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of Asia Pacific
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Latin America
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • Brazil
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of South America
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Middle East & Africa (MEA)
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • GCC Countries
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • South Africa
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of MEA
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)

KEY COMPANY PROFILES

  • Competitive Landscape
    • Total number of companies covered
      • Exhibit: companies covered in the report, 2021
    • Top companies market positioning
      • Exhibit: company positioning matrix, 2021
    • Top companies market Share
      • Exhibit: Pie chart analysis on company market share, 2021(%)

Methodology

For the Malaria Diagnostics Market, our research methodology involved a mixture of primary and secondary data sources. Key steps involved in the research process are listed below:

1. Information Procurement: This stage involved the procurement of Market data or related information via primary and secondary sources. The various secondary sources used included various company websites, annual reports, trade databases, and paid databases such as Hoover's, Bloomberg Business, Factiva, and Avention. Our team did 45 primary interactions Globally which included several stakeholders such as manufacturers, customers, key opinion leaders, etc. Overall, information procurement was one of the most extensive stages in our research process.

2. Information Analysis: This step involved triangulation of data through bottom-up and top-down approaches to estimate and validate the total size and future estimate of the Malaria Diagnostics Market.

3. Report Formulation: The final step entailed the placement of data points in appropriate Market spaces in an attempt to deduce viable conclusions.

4. Validation & Publishing: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helped us finalize data points to be used for final calculations. The final Market estimates and forecasts were then aligned and sent to our panel of industry experts for validation of data. Once the validation was done the report was sent to our Quality Assurance team to ensure adherence to style guides, consistency & design.

Analyst Support

Customization Options

With the given market data, our dedicated team of analysts can offer you the following customization options are available for the Malaria Diagnostics Market:

Product Analysis: Product matrix, which offers a detailed comparison of the product portfolio of companies.

Regional Analysis: Further analysis of the Malaria Diagnostics Market for additional countries.

Competitive Analysis: Detailed analysis and profiling of additional Market players & comparative analysis of competitive products.

Go to Market Strategy: Find the high-growth channels to invest your marketing efforts and increase your customer base.

Innovation Mapping: Identify racial solutions and innovation, connected to deep ecosystems of innovators, start-ups, academics, and strategic partners.

Category Intelligence: Customized intelligence that is relevant to their supply Markets will enable them to make smarter sourcing decisions and improve their category management.

Public Company Transcript Analysis: To improve the investment performance by generating new alpha and making better-informed decisions.

Social Media Listening: To analyze the conversations and trends happening not just around your brand, but around your industry as a whole, and use those insights to make better Marketing decisions.

$5,300
BUY NOW

REQUEST FOR SAMPLE

Want to customize this report?
REQUEST FREE CUSTOMIZATION

FAQs

Malaria Diagnostics Market size was valued at USD 844.51 Million in 2023 and is poised to grow from USD 884.46 Million in 2024 to USD 1340.65 Million by 2032, growing at a CAGR of 4.73% during the forecast period (2025-2032).

The global malaria diagnostics market is moderately competitive and consists of several major players. It is characterised by the presence of established multinational corporations, mid-sized companies, and emerging players. Key players such as Abbott Laboratories, BioMérieux SA, and F. Hoffmann-La Roche Ltd dominate the market with their extensive product portfolios, global presence, and strong distribution networks. These companies invest significantly in R&D activities to innovate and introduce advanced diagnostic technologies for malaria detection. Additionally, strategic collaborations, partnerships, and mergers and acquisitions are common strategies employed by market players to expand their market share and enhance their competitive position. However, the market also witnesses the entry of smaller players and startups focusing on niche segments or innovative diagnostic approaches, contributing to market dynamism and fostering competition. The competitive landscape of the malaria diagnostics market is driven by technological advancements, regulatory approvals, market expansion efforts, and the pursuit of novel diagnostic solutions to address the global burden of malaria effectively. 'Abbott Laboratories (United States)', 'Beckman Coulter, Inc. (United States)', 'BioMérieux SA (France)', 'Bio-Rad Laboratories, Inc. (United States)', 'Cepheid Inc. (United States)', 'Danaher Corporation (United States)', 'F. Hoffmann-La Roche Ltd (Switzerland)', 'FujiFilm Corporation (Japan)', 'GenMark Diagnostics, Inc. (United States)', 'Hologic, Inc. (United States)', 'Illumina, Inc. (United States)', 'Meridian Bioscience, Inc. (United States)', 'Qiagen NV (Netherlands)', 'Siemens Healthineers AG (Germany)', 'Sysmex Corporation (Japan)', 'Thermo Fisher Scientific Inc. (United States)', 'Bio-Rad Laboratories (United States)', 'Trinity Biotech plc (Ireland)', 'Siemens Healthineers (Germany)', 'Access Bio, Inc. (South Korea)'

Regions with a high burden of malaria, particularly in sub-Saharan Africa and parts of Asia, drive the demand for malaria diagnostics. The need for accurate and timely diagnosis is crucial for effective disease management and control.

Expansion into Emerging Markets: Emerging economies in Asia, Latin America, and Africa presents major growth opportunities for malaria diagnostics due to increasing healthcare expenditure, rising awareness about infectious diseases, and government initiatives to combat malaria. Companies can capitalize on these markets by offering cost-effective and culturally sensitive diagnostic solutions tailored to local needs.

Based on the geography, the global malaria diagnostics market is segmented into North America, Asia Pacific, Europe, Latin America, and Middle East & Africa. Middle East & Africa is considered as the leading region in the global malaria diagnostics market. The African region had the highest revenue share of 88.17% in 2022. P. falciparum is the most prevalent malarial parasite in this region and was accounted for an estimated 99% of all cases in Africa. According to the WHO, an estimated 92.0% of global malaria cases and 93% of global malarial deaths were recorded in this region. These facts are indicative of the rising prevalence of malaria in Africa. This region bears the highest burden of malaria globally, with a substantial portion of malaria cases and deaths occurring here. Factors contributing to the dominance of this segment include the endemic nature of malaria in many countries across Africa, where the disease is a major public health concern. Additionally, limited access to healthcare resources, including diagnostic facilities and trained personnel, often demands for the use of RDTs and other point-of-care diagnostics in resource-constrained settings. Moreover, international organizations, governments and non-profit organizations have been actively involved in scaling up malaria control and elimination efforts in the region, thereby driving the demand for malaria diagnostics.

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

logo-images

Feedback From Our Clients

Malaria Diagnostics Market

Report ID: SQMIG35B2208

sales@skyquestt.com
USA +1 351-333-4748

BUY NOW GET FREE SAMPLE